Categories AlphaGraphs, Earnings, Technology

Hewlett Packard Enterprise tops Q4 estimates, maintains FY19 outlook

Hewlett Packard Enterprise (HPE) reported its fourth quarter of 2018 earnings after the bell. The company posted earnings of $0.45 per share on revenue of $7.9 billion. The Street expected the IT giant to post earnings of about $0.43 per share on revenue of $7.85 billion. After the bell, the stock turned to red after trading in the positive territory for just half an hour.

HPE fourth quarter 2018 Earnings Infographic

Adjusted EPS of $0.45 was above the previously provided earnings outlook of $0.39 to $0.44 per share, while GAAP loss per share of $0.52 came in below the previously provided earnings outlook of $0.16 to $0.21 per share. GAAP loss per share was hurt by the U.S. Tax Reform charges of $1.3 billion in the final quarter of 2018.

Sales in the Asia-Pacific region experienced a 5% decline, while the Americas and EMEA regions experienced a growth of 3% and 11%, respectively.

The Palo Alto, California-based firm maintained its fiscal 2019 GAAP EPS outlook of $0.73 to $0.83 and non-GAAP EPS outlook of $1.51 to $1.61. For 1Q19, HPE estimates GAAP EPS to be in the range of $0.19 to $0.23 and non-GAAP EPS to be in the range of $0.33 to $0.37.

“In 2019, I have great confidence that our experienced global team and proven strategy will accelerate what comes next for our customers from edge to cloud,” said CEO Antonio Neri.

Hewlett Packard Enterprise stock gains after Q3 earnings beat

Shares of Hewlett Packard were hurt by the broader sell-off in the afternoon session and dropped 2.9% to $15.05 when the market closed on Tuesday. The company’s stock had produced a negative return of 10% in the past 3 months and it had given a positive return of 6% in the past 52-weeks period.

 

We’re on Apple News! Follow us to receive the latest stock market, earnings and financial news at your fingertips

 

Most Popular

Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO

Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training

INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues

Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came

Riding the AI wave, Nvidia looks set to stay on the high-growth path

After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top